Skip to main content
Top
Published in: Endocrine 2/2023

22-11-2022 | Insulins | Original Article

Longitudinal trends in lipid profile in indian children and youth with type-1 diabetes: a 5-year follow up from a single centre

Authors: Chirantap Oza, Anuradha Khadilkar, Shruti A. Mondkar, Ketan Gondhalekar, Vaman Khadilkar

Published in: Endocrine | Issue 2/2023

Login to get access

Abstract

Introduction

High prevalence of dyslipidaemia in children and adolescents with type-1 diabetes (T1D) places them at increased risk of developing atherosclerosis leading to mortality caused by cardiovascular disease(CVD). Thus, screening for fasting blood lipids when diabetes is stabilized in children aged 11 years and above is routinely recommended with follow-up every 5 years.

Objectives

(1) To characterize the lipid profile of children and adolescents with respect to diabetes duration. (2) To describe longitudinal changes in lipid profile over a 5-year period in patients with T1D.

Methods

This longitudinal 5-year follow-up study included 112 patients with T1D aged 3–18 years. Demographic data, anthropometry and laboratory measurements were performed using standard protocols at baseline and endline. P value < 0.05 was considered significant.

Results

The prevalence of dyslipidaemia in our study was 49.5% with abnormal LDL as the most frequently deranged parameter. Duration of illness played a major role in deterioration of lipid profile mediated by triglyceride and VLDL. Duration of illness and fibre intake in diet significantly predicted the change in lipid profile which were driven by triglycerides and VLDL. Glycemic control, insulin sensitivity and serum TSH also significantly altered components of lipid profile with no impact on overall dyslipidaemia. A total of 6.5% subjects had LDL concentrations >130 mg/dl and the same proportion had non-HDL cholesterol concentrations >145 mg/dl at baseline while at endline, 11.9% subjects had LDL concentrations >130 mg/dl and 15.6% subjects had non-HDL cholesterol concentrations >145 mg/dl. 28.6% subjects with LDL > 130 mg/dl and non-HDL cholesterol >145 mg/dl at baseline had persistently elevated concentrations while 10.3% and 14.4% additional subjects developed elevated LDL and non-HDL cholesterol concentrations respectively during the study period.

Conclusions

The deterioration of lipid profile in T1D, due to increase in disease duration was chiefly mediated by increase in serum triglyceride and VLDL concentrations which may be prevented by improving glycaemic control, insulin sensitivity and fibre intake in diet.
Literature
1.
go back to reference International Diabetes Federation. IDF Diabetes Atlas. 10th edn. International Diabetes Federation,, Brussels, Belgium), 2021) International Diabetes Federation. IDF Diabetes Atlas. 10th edn. International Diabetes Federation,, Brussels, Belgium), 2021)
2.
go back to reference N. Shah, A. Khadilkar, K. Gondhalekar, V. Khadilkar, Prevalence of dyslipidemia in Indian children with poorly controlled type 1 diabetes mellitus. Pediatr. Diabetes 21(6), 987–94 (2020)CrossRef N. Shah, A. Khadilkar, K. Gondhalekar, V. Khadilkar, Prevalence of dyslipidemia in Indian children with poorly controlled type 1 diabetes mellitus. Pediatr. Diabetes 21(6), 987–94 (2020)CrossRef
3.
go back to reference M. Loredana Marcovecchio, R. Neil Dalton, Toby, A. Prevost et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 32, 658 (2009)CrossRef M. Loredana Marcovecchio, R. Neil Dalton, Toby, A. Prevost et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 32, 658 (2009)CrossRef
4.
go back to reference B.A. Lemkes, J. Hermanides, J.H. Devries, F. Holleman, J.C. Meijers, J.B. Hoekstra, Hyperglycemia: a prothrombotic factor? J. Thromb. Haemost. 8(8), 1663–9 (2010)CrossRef B.A. Lemkes, J. Hermanides, J.H. Devries, F. Holleman, J.C. Meijers, J.B. Hoekstra, Hyperglycemia: a prothrombotic factor? J. Thromb. Haemost. 8(8), 1663–9 (2010)CrossRef
5.
go back to reference S.P. Laing, A.J. Swerdlow, S.D. Slater et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46, 760–76 (2003)CrossRef S.P. Laing, A.J. Swerdlow, S.D. Slater et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46, 760–76 (2003)CrossRef
6.
go back to reference T.K. Homma, C.M. Endo, T. Saruhashi, A.P. Mori, R.M. Noronha, O. Monte, L.E. Calliari, Dyslipidemia in young patients with type 1 diabetes mellitus. Arch. Endocrinol. Metab. 59, 215–9 (2015)CrossRef T.K. Homma, C.M. Endo, T. Saruhashi, A.P. Mori, R.M. Noronha, O. Monte, L.E. Calliari, Dyslipidemia in young patients with type 1 diabetes mellitus. Arch. Endocrinol. Metab. 59, 215–9 (2015)CrossRef
7.
go back to reference A.J. Jenkins, T.J. Lyons, D. Zheng et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64, 817–828 (2003)CrossRef A.J. Jenkins, T.J. Lyons, D. Zheng et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64, 817–828 (2003)CrossRef
8.
go back to reference R.E. Kavey, V. Allada, S.R. Daniels, L.L. Hayman, B.W. McCrindle, J.W. Newburger, R.S. Parekh, J. Steinberger, Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114, 2710–38 (2006)CrossRef R.E. Kavey, V. Allada, S.R. Daniels, L.L. Hayman, B.W. McCrindle, J.W. Newburger, R.S. Parekh, J. Steinberger, Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114, 2710–38 (2006)CrossRef
9.
go back to reference B.W. McCrindle, E.M. Urbina, B.A. Dennison, M.S. Jacobson, J. Steinberger, A.P. Rocchini, L.L. Hayman, S.R. Daniels, Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115(14 Apr), 1948–67 (2007)CrossRef B.W. McCrindle, E.M. Urbina, B.A. Dennison, M.S. Jacobson, J. Steinberger, A.P. Rocchini, L.L. Hayman, S.R. Daniels, Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115(14 Apr), 1948–67 (2007)CrossRef
10.
go back to reference K.C. Donaghue, M.L. Marcovecchio, R.P. Wadwa, E.Y. Chew, T.Y. Wong, L.E. Calliari, B. Zabeen, M.A. Salem, M.E. Craig, ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr. Diabetes 19(Suppl 27 Oct), 262 (2018)CrossRef K.C. Donaghue, M.L. Marcovecchio, R.P. Wadwa, E.Y. Chew, T.Y. Wong, L.E. Calliari, B. Zabeen, M.A. Salem, M.E. Craig, ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr. Diabetes 19(Suppl 27 Oct), 262 (2018)CrossRef
11.
go back to reference M. Stommel, C.A. Schoenborn, Variations in BMI and prevalence of health risks in diverse racial and ethnic populations. Obesity 18, 1821–6 (2010)CrossRef M. Stommel, C.A. Schoenborn, Variations in BMI and prevalence of health risks in diverse racial and ethnic populations. Obesity 18, 1821–6 (2010)CrossRef
12.
go back to reference N. Barbosa, C.E. Sanchez, J.A. Vera, W. Perez, J.C. Thalabard, M. Rieu, A physical activity questionnaire: Reproducibility and validity. J. Sport Sci. Med 6(4), 505–518 (2007) N. Barbosa, C.E. Sanchez, J.A. Vera, W. Perez, J.C. Thalabard, M. Rieu, A physical activity questionnaire: Reproducibility and validity. J. Sport Sci. Med 6(4), 505–518 (2007)
13.
go back to reference W.A. Marshall, J.M. Tanner, Variations in the pattern of pubertal changes in boys. Arch. Dis. Child 45(239), 13–23 (1970)CrossRef W.A. Marshall, J.M. Tanner, Variations in the pattern of pubertal changes in boys. Arch. Dis. Child 45(239), 13–23 (1970)CrossRef
14.
go back to reference W.A. Marshall, J.M. Tanner, Variations in pattern of pubertal changes in girls. Arch. Dis. Child 44(235), 291–303 (1969)CrossRef W.A. Marshall, J.M. Tanner, Variations in pattern of pubertal changes in girls. Arch. Dis. Child 44(235), 291–303 (1969)CrossRef
15.
go back to reference S.A. Chiplonkar, Trends in Nutrient Intakes of Indian Adults: Computerized Diet Analysis (CDiet) of Cross-sectional Surveys between 1998 and 2015. Curr. Nutr. Food Sci. 17, 423–32 (2021)CrossRef S.A. Chiplonkar, Trends in Nutrient Intakes of Indian Adults: Computerized Diet Analysis (CDiet) of Cross-sectional Surveys between 1998 and 2015. Curr. Nutr. Food Sci. 17, 423–32 (2021)CrossRef
16.
go back to reference V.V. Khadilkar, A.V. Khadilkar, Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5-18-year-old Indian children. Indian J. Endocrinol. Metab. 19(4), 470–476 (2015)CrossRef V.V. Khadilkar, A.V. Khadilkar, Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5-18-year-old Indian children. Indian J. Endocrinol. Metab. 19(4), 470–476 (2015)CrossRef
17.
go back to reference A. Khadilkar, V. Ekbote, S. Chiplonkar, V. Khadilkar, N. Kajale, S. Kulkarni, L. Parthasarathy, A. Arya, A. Bhattacharya, S. Agarwal, Waist circumference percentiles in 2-18 year old Indian children. The. J. Pediatrics 164(6), 1358–62 (2014)CrossRef A. Khadilkar, V. Ekbote, S. Chiplonkar, V. Khadilkar, N. Kajale, S. Kulkarni, L. Parthasarathy, A. Arya, A. Bhattacharya, S. Agarwal, Waist circumference percentiles in 2-18 year old Indian children. The. J. Pediatrics 164(6), 1358–62 (2014)CrossRef
18.
go back to reference G.R. Warnick, R.H. Knopp, V. Fitzpatrick, L. Branson, Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem. 36(1), 15–19 (1990)CrossRef G.R. Warnick, R.H. Knopp, V. Fitzpatrick, L. Branson, Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem. 36(1), 15–19 (1990)CrossRef
19.
go back to reference Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute, Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(5), 213–256 (2011) Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute, Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(5), 213–256 (2011)
20.
go back to reference D.B. Petitti, G.J. Klingensmith, R.A. Bell, J.S. Andrews, D. Dabelea, G. Imperatore, S. Marcovina, C. Pihoker, D. Standiford, B. Waitzfelder, E. Mayer-Davis, Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J. Pediatrics 155(5), 668–72 (2009)CrossRef D.B. Petitti, G.J. Klingensmith, R.A. Bell, J.S. Andrews, D. Dabelea, G. Imperatore, S. Marcovina, C. Pihoker, D. Standiford, B. Waitzfelder, E. Mayer-Davis, Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J. Pediatrics 155(5), 668–72 (2009)CrossRef
21.
go back to reference K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626–632 (2000)CrossRef K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626–632 (2000)CrossRef
22.
go back to reference E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the diabetes control and complications trial. Diabetes care 30(3), 707–12. (2007)CrossRef E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the diabetes control and complications trial. Diabetes care 30(3), 707–12. (2007)CrossRef
23.
go back to reference M.J. Redondo, N.C. Foster, I.M. Libman, S.N. Mehta, J.M. Hathway et al. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 53, 271–7 (2016)CrossRef M.J. Redondo, N.C. Foster, I.M. Libman, S.N. Mehta, J.M. Hathway et al. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 53, 271–7 (2016)CrossRef
24.
go back to reference H. Soliman, A. Ibrahim, Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes. Egypt. Pediatr. Assoc. Gaz. 69(1), 1–7 (2021) H. Soliman, A. Ibrahim, Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes. Egypt. Pediatr. Assoc. Gaz. 69(1), 1–7 (2021)
25.
go back to reference American Diabetes Association, Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 41(1), S86–S104 (2018)CrossRef American Diabetes Association, Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 41(1), S86–S104 (2018)CrossRef
26.
go back to reference B. Zabeen, A.M. Balsa, N. Islam, M. Parveen, J. Nahar, K. Azad, Lipid profile in relation to glycemic control in type 1 diabetes children and adolescents in Bangladesh. Indian J. Endocrinol. Metab. 22(1), 89–92 (2018)CrossRef B. Zabeen, A.M. Balsa, N. Islam, M. Parveen, J. Nahar, K. Azad, Lipid profile in relation to glycemic control in type 1 diabetes children and adolescents in Bangladesh. Indian J. Endocrinol. Metab. 22(1), 89–92 (2018)CrossRef
27.
go back to reference S.R. Joshi, R.M. Anjana, M. Deepa, R. Pradeepa, A. Bhansali, V.K. Dhandania et al. Prevalence of dyslipidemia in urban and rural India: The ICMR INDIAB study. PLoS One 9, e96808 (2014)CrossRef S.R. Joshi, R.M. Anjana, M. Deepa, R. Pradeepa, A. Bhansali, V.K. Dhandania et al. Prevalence of dyslipidemia in urban and rural India: The ICMR INDIAB study. PLoS One 9, e96808 (2014)CrossRef
28.
go back to reference A.S. Shah, D.M. Maahs, J.M. Stafford, L.M. Dolan, W. Lang, G. Imperatore, R.A. Bell, A.D. Liese, K. Reynolds, C. Pihoker, S. Marcovina, Predictors of dyslipidemia over time in youth with type 1 diabetes: for the SEARCH for Diabetes in Youth study. Diabetes Care 40(4), 607–13 (2017)CrossRef A.S. Shah, D.M. Maahs, J.M. Stafford, L.M. Dolan, W. Lang, G. Imperatore, R.A. Bell, A.D. Liese, K. Reynolds, C. Pihoker, S. Marcovina, Predictors of dyslipidemia over time in youth with type 1 diabetes: for the SEARCH for Diabetes in Youth study. Diabetes Care 40(4), 607–13 (2017)CrossRef
29.
go back to reference J.A. Edge, T. James, B. Shine, Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population. Diabet. Med. 25(8), 942–8 (2008)CrossRef J.A. Edge, T. James, B. Shine, Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population. Diabet. Med. 25(8), 942–8 (2008)CrossRef
30.
go back to reference D.M. Maahs, R.P. Wadwa, K. McFann, K. Nadeau, M.R. Williams, R.H. Eckel et al. Longitudinal lipid screening and use of lipid-lowering medications in pediatric Type 1 diabetes. J. Pediatr. 150, 146–150 (2007)CrossRef D.M. Maahs, R.P. Wadwa, K. McFann, K. Nadeau, M.R. Williams, R.H. Eckel et al. Longitudinal lipid screening and use of lipid-lowering medications in pediatric Type 1 diabetes. J. Pediatr. 150, 146–150 (2007)CrossRef
31.
go back to reference C. Oza, A. Khadilkar, M. Karguppikar, K. Gondhalekar, V. Khadilkar, Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes. J. Pediatr. Endocrinol. Metab. 35(8), 1010–9 (2022)CrossRef C. Oza, A. Khadilkar, M. Karguppikar, K. Gondhalekar, V. Khadilkar, Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes. J. Pediatr. Endocrinol. Metab. 35(8), 1010–9 (2022)CrossRef
33.
go back to reference K.J. Nadeau, J.G. Regensteiner, T.A. Bauer et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J. Clin. Endocrinol. Metab. 95, 513–521 (2010)CrossRef K.J. Nadeau, J.G. Regensteiner, T.A. Bauer et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J. Clin. Endocrinol. Metab. 95, 513–521 (2010)CrossRef
34.
go back to reference K.O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents, and young adults with Type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 29, 218–225 (2006)CrossRef K.O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents, and young adults with Type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 29, 218–225 (2006)CrossRef
35.
go back to reference M.L. Fernandez, Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr. Opin. Lipidol. 12, 35–40 (2001)CrossRef M.L. Fernandez, Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr. Opin. Lipidol. 12, 35–40 (2001)CrossRef
36.
go back to reference S. Larrosa, V. Luque, V. Grote, R. Closa-Monasterolo, N. Ferré, B. Koletzko, E. Verduci, D. Gruszfeld, A. Xhonneux, J. Escribano, Fibre intake is associated with cardiovascular health in european children. Nutrients 13(1), 12 (2021)CrossRef S. Larrosa, V. Luque, V. Grote, R. Closa-Monasterolo, N. Ferré, B. Koletzko, E. Verduci, D. Gruszfeld, A. Xhonneux, J. Escribano, Fibre intake is associated with cardiovascular health in european children. Nutrients 13(1), 12 (2021)CrossRef
37.
go back to reference C. Denzer, B. Karges, A. Näke et al. Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus. Eur. J. Endocrinol. 168(4), 601–608 (2013)CrossRef C. Denzer, B. Karges, A. Näke et al. Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus. Eur. J. Endocrinol. 168(4), 601–608 (2013)CrossRef
38.
go back to reference S.J. Bakker, J.C. ter Maaten, C. Popp-Snijders, J.P. Slaets, R.J. Heine, R.O. Gans, The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 86, 1206–1211 (2001) S.J. Bakker, J.C. ter Maaten, C. Popp-Snijders, J.P. Slaets, R.J. Heine, R.O. Gans, The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 86, 1206–1211 (2001)
39.
go back to reference A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)CrossRef A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)CrossRef
40.
go back to reference B.O. Åsvold, L.J. Vatten, T.I. Nilsen, T. Bjøro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156(2), 181–6 (2007)CrossRef B.O. Åsvold, L.J. Vatten, T.I. Nilsen, T. Bjøro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156(2), 181–6 (2007)CrossRef
Metadata
Title
Longitudinal trends in lipid profile in indian children and youth with type-1 diabetes: a 5-year follow up from a single centre
Authors
Chirantap Oza
Anuradha Khadilkar
Shruti A. Mondkar
Ketan Gondhalekar
Vaman Khadilkar
Publication date
22-11-2022
Publisher
Springer US
Published in
Endocrine / Issue 2/2023
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03259-6

Other articles of this Issue 2/2023

Endocrine 2/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.